|
|
||||||||
Production by NK-T Cells1


*
Department of Pathology, Loyola University Medical Center, Maywood, IL 60153;
Department of Dermatology, Institut National de la Santé et de la Recherche Médicale, Unité 346, Hopital Edouard Herriot, Lyon, France;
Department of Dermatology, University of California School of Medicine, Los Angeles, CA 90024; and
§
Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461
The MHC class I-like protein CD1d is a nonpolymorphic molecule that
plays a central role in development and activation of a subset of T
cells that coexpress receptors used by NK cells (NK-T cells). Recently,
T cells bearing NK receptors were identified in acute and chronic
lesions of psoriasis. To determine whether NK-T cells could interact
with epidermal cells, we examined the pattern of expression of CD1d in
normal skin, psoriasis, and related skin disorders, using a panel of
CD1d-specific mAbs. CD1d was expressed by keratinocytes in normal skin,
although expression was at a relatively low level and was generally
confined to upper level keratinocytes immediately beneath the
lipid-rich stratum corneum. In contrast, there was overexpression of
CD1d in chronic, active psoriatic plaques. CD1d could be rapidly
induced on keratinocytes in normal skin by physical trauma that
disrupted barrier function or by application of a potent
contact-sensitizing agent. Keratinocytes displayed enhanced CD1d
following exposure to IFN-
. Combining CD1d-positive keratinocytes
with human NK-T cell clones resulted in clustering of NK-T cells, and
while no significant proliferation ensued, NK-T cells became activated
to produce large amounts of IFN-
. We conclude that CD1d can be
expressed in a functionally active form by keratinocytes and is
up-regulated in psoriasis and other inflammatory dermatoses. The
ability of IFN-
to enhance keratinocyte CD1d expression and the
subsequent ability of CD1d-positive keratinocytes to activate NK-T
cells to produce IFN-
, could provide a mechanism that contributes to
the pathogenesis of psoriasis and other skin
disorders.
This article has been cited by other articles:
![]() |
K. Kawana, J. Matsumoto, S. Miura, L. Shen, Y. Kawana, T. Nagamatsu, T. Yasugi, T. Fujii, H. Yang, A. J. Quayle, et al. Expression of CD1d and Ligand-Induced Cytokine Production Are Tissue Specific in Mucosal Epithelia of the Human Lower Reproductive Tract Infect. Immun., July 1, 2008; 76(7): 3011 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. N. Rees, L. Pazmany, D. Gutowska-Owsiak, C. F. Inman, A. Phillips, C. R. Stokes, N. Johnston, J. A. Koufman, G. Postma, M. Bailey, et al. The Mucosal Immune Response to Laryngopharyngeal Reflux Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1187 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Im, N. Tapinos, G.-T. Chae, P. A. Illarionov, G. S. Besra, G. H. DeVries, R. L. Modlin, P. A. Sieling, A. Rambukkana, and S. A. Porcelli Expression of CD1d Molecules by Human Schwann Cells and Potential Interactions with Immunoregulatory Invariant NK T Cells J. Immunol., October 15, 2006; 177(8): 5226 - 5235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fishelevich, A. Malanina, I. Luzina, S. Atamas, M. J. Smyth, S. A. Porcelli, and A. A. Gaspari Ceramide-Dependent Regulation of Human Epidermal Keratinocyte CD1d Expression during Terminal Differentiation J. Immunol., February 15, 2006; 176(4): 2590 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Adley, H A Assaf, and M Hussein Expression of CD1d in human scalp skin and hair follicles: hair cycle related alterations J. Clin. Pathol., December 1, 2005; 58(12): 1278 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O. A. Yu, J. S. Im, A. Molano, Y. Dutronc, P. A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of {alpha}-galactosylceramides PNAS, March 1, 2005; 102(9): 3383 - 3388. [Abstract] [Full Text] [PDF] |
||||
![]() |
J G Krueger and A Bowcock Psoriasis pathophysiology: current concepts of pathogenesis Ann Rheum Dis, March 1, 2005; 64(suppl_2): ii30 - ii36. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsumura, A. M. Moodycliffe, D. X. Nghiem, S. E. Ullrich, and H. N. Ananthaswamy Resistance of CD1d-/- Mice to Ultraviolet-Induced Skin Cancer Is Associated with Increased Apoptosis Am. J. Pathol., September 1, 2004; 165(3): 879 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Y. Chen and N. Jackson Human CD1D Gene Has TATA Boxless Dual Promoters: An SP1-Binding Element Determines the Function of the Proximal Promoter J. Immunol., May 1, 2004; 172(9): 5512 - 5521. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. J. van der Vliet, J. W. Molling, N. Nishi, A. J. Masterson, W. Kolgen, S. A. Porcelli, A. J. M. van den Eertwegh, B. M. E. von Blomberg, H. M. Pinedo, G. Giaccone, et al. Polarization of V{alpha}24+ V{beta}11+ Natural Killer T Cells of Healthy Volunteers and Cancer Patients Using {alpha}-Galactosylceramide-loaded and Environmentally Instructed Dendritic Cells Cancer Res., July 15, 2003; 63(14): 4101 - 4106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gansert, V. Kiebler, M. Engele, F. Wittke, M. Rollinghoff, A. M. Krensky, S. A. Porcelli, R. L. Modlin, and S. Stenger Human NKT Cells Express Granulysin and Exhibit Antimycobacterial Activity J. Immunol., March 15, 2003; 170(6): 3154 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mizukawa, Y. Yamazaki, Y. Teraki, J. Hayakawa, K. Hayakawa, H. Nuriya, M. Kohara, and T. Shiohara Direct Evidence for Interferon-{gamma} Production by Effector-Memory-Type Intraepidermal T Cells Residing at an Effector Site of Immunopathology in Fixed Drug Eruption Am. J. Pathol., October 1, 2002; 161(4): 1337 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mempel, C. Ronet, F. Suarez, M. Gilleron, G. Puzo, L. Van Kaer, A. Lehuen, P. Kourilsky, and G. Gachelin Natural Killer T Cells Restricted by the Monomorphic MHC Class 1b CD1d1 Molecules Behave Like Inflammatory Cells J. Immunol., January 1, 2002; 168(1): 365 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.M. Rhind CD1--The Pathology Perspective Vet. Pathol., November 1, 2001; 38(6): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Metelitsa, O. V. Naidenko, A. Kant, H.-W. Wu, M. J. Loza, B. Perussia, M. Kronenberg, and R. C. Seeger Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells J. Immunol., September 15, 2001; 167(6): 3114 - 3122. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |